Show simple item record

dc.contributor.authorLiz, Joao Carlos Batista
dc.contributor.authorMárquez, Ana
dc.contributor.authorOrtego Centeno, Norberto 
dc.contributor.authorMartín, Javier
dc.date.accessioned2022-11-03T09:23:10Z
dc.date.available2022-11-03T09:23:10Z
dc.date.issued2022-09-22
dc.identifier.citationBatista Liz, J.C... [et al.]. IgA Vasculitis: Influence of CD40, BLK and BANK1 Gene Polymorphisms. J. Clin. Med. 2022, 11, 5577. [https://doi.org/10.3390/jcm11195577]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/77724
dc.description.abstractCD40, BLK and BANK1 genes involved in the development and signaling of B-cells are identified as susceptibility loci for numerous inflammatory diseases. Accordingly, we assessed the potential influence of CD40, BLK and BANK1 on the pathogenesis of immunoglobulin-A vasculitis (IgAV), predominantly a B-lymphocyte inflammatory condition. Three genetic variants within CD40 (rs1883832, rs1535045, rs4813003) and BLK (rs2254546, rs2736340, rs2618476) as well as two BANK1 polymorphisms (rs10516487, rs3733197), previously associated with inflammatory diseases, were genotyped in 382 Caucasian patients with IgAV and 955 sex- and ethnically matched healthy controls. No statistically significant differences were observed in the genotype and allele frequencies of CD40, BLK and BANK1 when IgAV patients and healthy controls were compared. Similar results were found when CD40, BLK and BANK1 genotypes or alleles frequencies were compared between patients with IgAV stratified according to the age at disease onset or to the presence/absence of gastrointestinal or renal manifestations. Moreover, no CD40, BLK and BANK1 haplotype differences were disclosed between patients with IgAV and healthy controls and between patients with IgAV stratified according to the clinical characteristics mentioned above. Our findings indicate that CD40, BLK and BANK1 do not contribute to the genetic background of IgAV.es_ES
dc.description.sponsorshipEuropean Commissiones_ES
dc.description.sponsorshipInstituto de Salud Carlos III" (ISCIII, Health Ministry, Spain) PI18/00042 PI21/00042 Instituto de Salud Carlos IIIes_ES
dc.description.sponsorshipEuropean Social Fund (ESF) CM20/00006es_ES
dc.description.sponsorshipRICORS Program from ISCIIIes_ES
dc.description.sponsorshipEuropean Commission RD21/0002/0025es_ES
dc.description.sponsorshipRETICS Program (ISCIII) RD16/0012/0009es_ES
dc.description.sponsorshipRETICS Program (European Regional Development Fund (ERDF) RD16/0012/0009es_ES
dc.description.sponsorshipEuropean Union FEDER fund RD16/0012/0014 PI17/00409es_ES
dc.description.sponsorshipResearch Executive Agency (REA) of the European Union 734899es_ES
dc.description.sponsorshipMiguel Servet type II program fellowship from the ISCIIIes_ES
dc.description.sponsorshipESF ("Investing in your future") CPII21/00004es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectIgA vasculitises_ES
dc.subjectHenoch-Schönlein purpuraes_ES
dc.subjectCD40es_ES
dc.subjectBLKes_ES
dc.subjectBANK1es_ES
dc.subjectPolymorphismses_ES
dc.titleIgA Vasculitis: Influence of CD40, BLK and BANK1 Gene Polymorphismses_ES
dc.typejournal articlees_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/734899es_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/jcm11195577
dc.type.hasVersionVoRes_ES


Files in this item

[PDF]

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
Except where otherwise noted, this item's license is described as Atribución 4.0 Internacional